Is cdt stock a good stock to buy today

**Conduit Pharmaceuticals Inc. (CDT) does not appear to be a good stock to buy today**, based on the following analysis:

1. **Recent Performance**: CDT has experienced a significant decline, with a 1-month percentage change of -94.86% and a 3-month percentage change of -93.98%. This indicates a recent period of heavy selling, which may be indicative of market concerns or negative outlook for the company.

|Ticker|Name|Interval Percentage Change|Date|code|market_code|
|---|---|---|---|---|---|
|CDT.O|Conduit|-93.97810218978103|20240208-20240807|CDT|185|
|CDT.O|Conduit|-94.85981308411215|20240508-20240807|CDT|185|
|CDT.O|Conduit|-68.92655367231639|20240708-20240807|CDT|185|

2. **Technical Indicators**: The stock's MACD is at 0.13, KDJ is at 8.19, and RSI is at 15.3, which are all below their respective neutral levels. These indicators suggest that the stock may be oversold, which could be a sign of a potential rebound. However, they also indicate that the stock is not in a strong technical position at the moment.

|Ticker|Name|MACD|KDJ|RSI|Date|code|market_code|
|---|---|---|---|---|---|---|---|
|CDT.O|Conduit|0.1297|8.1892|15.3030|20240807|CDT|185|

3. **Moving Averages**: The 5-day moving average is $0.19 and the 10-day moving average is $0.21. The fact that the stock is currently trading below these short-term moving averages could be seen as a bearish signal.

|Ticker|Name|5-Day Moving Average|10-Day Moving Average|Date|code|market_code|
|---|---|---|---|---|---|---|
|CDT.O|Conduit|0.1868|0.2104|20240807|CDT|185|

4. **Price Forecast**: The forecast price for CDT over the next ten trading days is expected to range from $0.16 to $0.18, which is below the current trading price. This suggests that the market does not expect a significant increase in the stock's price in the near term.

|Ticker|Name|Forecast Price|Date|code|market_code|
|---|---|---|---|---|---|
|CDT.O|Conduit|0.1639039|20240808|CDT|185|
|CDT.O|Conduit|0.16627586|20240809|CDT|185|
|CDT.O|Conduit|0.17002357|20240812|CDT|185|
|CDT.O|Conduit|0.1784341|20240813|CDT|185|
|CDT.O|Conduit|0.18319843|20240814|CDT|185|
|CDT.O|Conduit|0.1966834|20240815|CDT|185|
|CDT.O|Conduit|0.18941386|20240816|CDT|185|
|CDT.O|Conduit|0.18385123|20240819|CDT|185|
|CDT.O|Conduit|0.18183904|20240820|CDT|185|
|CDT.O|Conduit|0.17726976|20240821|CDT|185|

5. **Market Capitalization and Financial Health**: With a market cap of $12.18 million and a current ratio of 1.59, the company is relatively small and may be vulnerable to market fluctuations. The current ratio suggests that the company has enough current assets to cover its current liabilities, but it is not in a strong financial position.

|Ticker|Name|5-Day Moving Average|10-Day Moving Average|Date|code|market_code|
|---|---|---|---|---|---|---|
|CDT.O|Conduit|0.1868|0.2104|20240807|CDT|185|

6. **Recent News**: There is no recent news about Conduit Pharmaceuticals that would indicate a positive outlook for the stock. The company has not paid any dividends and has a negative EPS. Additionally, the stock is not covered by any analysts, which could be a sign of lack of interest or uncertainty about the company's future prospects.

In conclusion, while the oversold technical indicators may suggest a potential for a rebound, the overall negative trend, lack of positive news, and the stock's current trading below key moving averages argue against considering CDT as a good stock to buy today. Investors should exercise caution and consider these factors before making an investment decision.